Typicality: | 0.399 |
Saliency: | 0.223 |
as part of the approval package | 2 | manner |
trial → be submitted to → the fda | 9 |
trial → be reviewed by → the fda | 3 |
negative | neutral | positive |
0.119 | 0.750 | 0.132 |
Raw frequency | 12 |
Normalized frequency | 0.223 |
Modifier score | 0.667 |
Perplexity | 64.524 |